| Tag | Content |
|---|
EnhancerAtlas ID | HS182-11614 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr19:50057820-50058640 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr19:50057871-50057886 | TGAACTCCTGACCTC | - | 6.22 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_18817 | chr19:50054487-50069860 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19587 | chr19:50055882-50059429 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_50670 | chr19:50056585-50058623 | Sigmoid_Colon | | SE_62028 | chr19:50036137-50074396 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr19 | 50057932 | 50058504 | | chr19 | 50057839 | 50057919 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I049552 | chr19 | 50055756 | 50061457 |
|
Enhancer Sequence | GTGCTGGGAT TACAGGCGTG AGCCACCGCA CCCGGCTATC TAGGCTGGTC TTGAACTCCT 60
GACCTCAAGT GATCCACCCG CCTCAGATTC CCAAAGTGCT GGGATTACAG GCGTGAGCCA 120
CCGCACCCGG CCTGTCTTGT TTTAATCTTT GCTTGTCTCC GTGCTGTTTT TCACACTGCC 180
CAGCAGCTGC TTTTGTGACT CAATGGTTAT TAAACACAAG GCCTTAAGGA CAGCCCCTAC 240
ATTCCCAGTC AAGTCTGACG CCACCGGGCT GGTTCCTGGT CCCCGCTCTG CCCTGGCTCC 300
CTCACTCTCC CCTGTACGCC CTCTGCTCCT TAAATCTGCA AAGTGCGTTG CTGCCTCTGG 360
GCCTTTGCAC TCGCGGTTTC CTCTTCCTTT CCCCCTCAGG CTGCCACAGG TGGGGGCGTG 420
ATGCTCCTGA CCGCCTTTCC TAGTCCGGGT GCTGCGCACT TTTTCACAGA ACTGCACTTC 480
CTTTGTGGGT CTAATCACAC TGCAGCCCGG AAGACACGTT CCTGGGCATT TCCTGTTCTT 540
CAAACCTGGC AAAAATCCGG GAACCCTAAC AAAGAACTCG AGAAATTTCT ATGTAGCTCA 600
TTAAAGTGGC GCACTCACAC GGTCTTGGCT TAGACTTGGA CTTCCGGCCA CTCAACCAAT 660
TTTAATGCTG TGCATTTGCG TTCTATTCAG GTTTTTTTTT TTTTTTCTTC TTTGAGATGG 720
AGTCTCGCTC TGTTGCCCAG GCTGAAGTGC AATGGTGCGA TCTTGGCTCA CTGCAACCTC 780
CGCCTCCTGG GTTCAAGCGA TTCTCCTGCC TCAGCCTCTG 820
|
